Infant Crying, a Bioacoustic Prognostic Signal for Neurodevelopment

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 4
SponsorCentre Hospitalier Universitaire de Saint Etienne

About this trial

Crying is a vital communication signal for the baby. Product of a complex physiological process, it reflects not only the organization and functioning of the cortical central nervous system and the function of sympathetic and parasympathetic autonomic regulation but also the integrity of three entities: the lungs responsible for ventilatory mechanics and respiratory rhythm, the larynx and its vocal cords as a phonatory organ, and the oropharyngeal tract guaranteeing the resonance of the sound emitted by the vocal cords.

Crying is usually caused by pain, discomfort, hunger, or separation from parents or other caregivers. Crying carries essential information from birth, the expression of which depends closely on the neuroanatomical and functional brain integrity of the child. On a bioacoustic level, crying consists of sequences of complex acoustic signals produced by the vocal folds and filtered by the vocal tract. The vibration frequency of the vocal cords determines the cry's fundamental frequency f0 (and the harmonic frequencies), which is responsible for its more or less low or high pitch. Other acoustic cues also characterize each baby's cry.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

For a full-term baby > 37 weeks

For a premature baby < 37 weeks

Born in the maternity ward of the Saint-Etienne University Hospital

Holder of parental authority having received informed information about the study and their right to object

Disqualifiers

Refusal of participation by the holder of parental authority

Antenatal pathology, nor perinatal asphyxia

Holder of minor parental authority

Holder of parental authority under curatorship or guardianship

Trial population

Full-term baby \> 37 weeks Premature baby \< 37 weeks

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Acoustic signal analysis method

    Other intervention

    Evaluate at birth in 2 characterized populations of babies born at term or prematurely, the correlation between bioacoustic characteristic of a cry specific to each baby, with the neurodevelopmental data at 2 years.

Treatment groups

1,100 Participants
are divided into 2 treatment groups
Group A: birth of term babies1 intervention
Group B: Premature babies1 intervention

Trial outcomes

Primary outcomes

1

Fundamental frequency f0 (Hz)

Fundamental frequency f0 (Hz) defined from a crying sequence, the most characteristic elementary index of their individual bioacoustic signature.

Time frame
At inclusion
2

Bailey-4 quantitative scale

neurodevelopment at age 2 measured by the Bailey-4 quantitative scale. The final score is from 40 (Very weak neurodevelopment) to 160 (Very good neurodevelopment)

Time frame
At 2 years

Secondary outcomes

1

Percentage voiced frames

Other bioacoustic characteristics measurable in each bioacoustic sequence

Time frame
At inclusion
2

Harmonics of f0 (Hz)

Other bioacoustic characteristics measurable in each bioacoustic sequence : vibration frequency of the vocal cords, defining a +/- low or high tone

Time frame
At inclusion
3

Median pitch f0 (Hz)

Other bioacoustic characteristics measurable in each bioacoustic sequence

Time frame
At inclusion
4

Harmonicity (dB)

Other bioacoustic characteristics measurable in each bioacoustic sequence

Time frame
At inclusion

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.